Product Code: TMRGL1415
The report provides revenue of the global respiratory monitoring devices market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global respiratory monitoring devices market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the respiratory monitoring devices market.
The report delves into the competitive landscape of the global respiratory monitoring devices market. Key players operating in the global respiratory monitoring devices market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global respiratory monitoring devices market profiled in this report.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Respiratory Monitoring Devices Market
4. Market Overview
- 4.1. Introduction
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Respiratory Monitoring Devices Market Analysis and Forecast, 2017-2027
5. Key Insights
- 5.1. Technological Advancements
- 5.2. Prevalence of Asthma & COPD by Region/Country
- 5.3. Annual Cost of COPD and Asthma
- 5.4. Key Industry Events (Mergers, Acquisitions, Collaborations, Launch & Approvals, etc.)
- 5.5. Reimbursement Scenario
- 5.6. Overview of respiratory disease monitoring in homecare settings
6. Global Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Product
- 6.1. Introduction & Definition
- 6.2. Global Respiratory Monitoring Devices Market Value Forecast, by Product, 2017-2027
- 6.2.1. Pulse Oximeters
- 6.2.2. Capnographs
- 6.2.3. Spirometers
- 6.2.4. Polysomnographs (PSG)
- 6.2.5. Peak Flow Meters
- 6.2.6. Gas Analyzers
- 6.2.7. Others
- 6.3. Global Respiratory Monitoring Devices Market Attractiveness, by Product
7. Global Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by End-user
- 7.1. Introduction
- 7.2. Global Respiratory Monitoring Devices Market Value Forecast, by End-user, 2017-2027
- 7.2.1. Home Care
- 7.2.2. Hospitals
- 7.2.3. Ambulatory Surgical Centers
- 7.2.4. Specialty Clinics
- 7.3. Global Respiratory Monitoring Devices Market Attractiveness, by End-user
8. Global Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Region
- 8.1. Introduction
- 8.2. Global Respiratory Monitoring Devices Market Value Forecast, by Region, 2017-2027
- 8.2.1. North America
- 8.2.2. Europe
- 8.2.3. Asia Pacific
- 8.2.4. Latin America
- 8.2.5. Middle East & Africa
- 8.3. Global Respiratory Monitoring Devices Market Attractiveness, by Region
9. North America Respiratory Monitoring Devices Market Analysis and Forecast
- 9.1. Introduction
- 9.2. North America Respiratory Monitoring Devices Market Value Forecast, by Product, 2017-2027
- 9.2.1. Pulse Oximeters
- 9.2.2. Capnographs
- 9.2.3. Spirometers
- 9.2.4. Polysomnographs (PSG)
- 9.2.5. Peak Flow Meters
- 9.2.6. Gas Analyzers
- 9.2.7. Others
- 9.3. North America Respiratory Monitoring Devices Market Value Forecast, by End-user, 2017-2027
- 9.3.1. Home Care
- 9.3.2. Hospitals
- 9.3.3. Ambulatory Surgical Centers
- 9.3.4. Specialty Clinics
- 9.4. North America Respiratory Monitoring Devices Market Value Forecast, by Country, 2017-2027
- 9.4.1. U.S.
- 9.4.2. Canada
- 9.5. North America Respiratory Monitoring Devices Market Attractiveness Analysis
- 9.5.1. By Product
- 9.5.2. By End-user
- 9.5.3. By Country
10. Europe Respiratory Monitoring Devices Market Analysis and Forecast
- 10.1. Introduction
- 10.2. Europe Respiratory Monitoring Devices Market Value Forecast, by Product, 2017-2027
- 10.2.1. Pulse Oximeters
- 10.2.2. Capnographs
- 10.2.3. Spirometers
- 10.2.4. Polysomnographs (PSG)
- 10.2.5. Peak Flow Meters
- 10.2.6. Gas Analyzers
- 10.2.7. Others
- 10.3. Europe Respiratory Monitoring Devices Market Value Forecast, by End-user, 2017-2027
- 10.3.1. Home Care
- 10.3.2. Hospitals
- 10.3.3. Ambulatory Surgical Centers
- 10.3.4. Specialty Clinics
- 10.4. Europe Respiratory Monitoring Devices Market Value Forecast, by Country/Sub-region, 2017-2027
- 10.4.1. Germany
- 10.4.2. U.K.
- 10.4.3. France
- 10.4.4. Spain
- 10.4.5. Italy
- 10.4.6. Rest of Europe
- 10.5. Europe Respiratory Monitoring Devices Market Attractiveness Analysis
- 10.5.1. By Product
- 10.5.2. By End-user
- 10.5.3. By Country/Sub-region
11. Asia Pacific Respiratory Monitoring Devices Market Analysis and Forecast
- 11.1. Introduction
- 11.2. Asia Pacific Respiratory Monitoring Devices Market Value Forecast, by Product, 2017-2027
- 11.2.1. Pulse Oximeters
- 11.2.2. Capnographs
- 11.2.3. Spirometers
- 11.2.4. Polysomnographs (PSG)
- 11.2.5. Peak Flow Meters
- 11.2.6. Gas Analyzers
- 11.2.7. Others
- 11.3. Asia Pacific Respiratory Monitoring Devices Market Value Forecast, by End-user, 2017-2027
- 11.3.1. Home Care
- 11.3.2. Hospitals
- 11.3.3. Ambulatory Surgical Centers
- 11.3.4. Specialty Clinics
- 11.4. Asia Pacific Respiratory Monitoring Devices Market Value Forecast, by Country/Sub-region, 2017-2027
- 11.4.1. Japan
- 11.4.2. China
- 11.4.3. India
- 11.4.4. Australia & New Zealand
- 11.4.5. Rest of Asia Pacific
- 11.5. Asia Pacific Respiratory Monitoring Devices Market Attractiveness Analysis
- 11.5.1. By Product
- 11.5.2. By End-user
- 11.5.3. By Country/Sub-region
12. Latin America Respiratory Monitoring Devices Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Latin America Respiratory Monitoring Devices Market Value Forecast, by Product, 2017-2027
- 12.2.1. Pulse Oximeters
- 12.2.2. Capnographs
- 12.2.3. Spirometers
- 12.2.4. Polysomnographs (PSG)
- 12.2.5. Peak Flow Meters
- 12.2.6. Gas Analyzers
- 12.2.7. Others
- 12.3. Latin America Respiratory Monitoring Devices Market Value Forecast, by End-user, 2017-2027
- 12.3.1. Home Care
- 12.3.2. Hospitals
- 12.3.3. Ambulatory Surgical Centers
- 12.3.4. Specialty Clinics
- 12.4. Latin America Respiratory Monitoring Devices Market Value Forecast, by Country/Sub-region, 2017-2027
- 12.4.1. Brazil
- 12.4.2. Mexico
- 12.4.3. Rest of Latin America
- 12.5. Latin America Respiratory Monitoring Devices Market Attractiveness Analysis
- 12.5.1. By Product
- 12.5.2. By End-user
- 12.5.3. By Country/Sub-region
13. Middle East & Africa Respiratory Monitoring Devices Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Middle East & Africa Respiratory Monitoring Devices Market Value Forecast, by Product, 2017-2027
- 13.2.1. Pulse Oximeters
- 13.2.2. Capnographs
- 13.2.3. Spirometers
- 13.2.4. Polysomnographs (PSG)
- 13.2.5. Peak Flow Meters
- 13.2.6. Gas Analyzers
- 13.2.7. Others
- 13.3. Middle East & Africa Respiratory Monitoring Devices Market Value Forecast, by End-user, 2017-2027
- 13.3.1. Home Care
- 13.3.2. Hospitals
- 13.3.3. Ambulatory Surgical Centers
- 13.3.4. Specialty Clinics
- 13.3.5. Hospitals
- 13.4. Middle East & Africa Respiratory Monitoring Devices Market Value Forecast, by Country/Sub-region, 2017-2027
- 13.4.1. GCC Countries
- 13.4.2. South Africa
- 13.4.3. Rest of Middle East & Africa
- 13.5. Middle East & Africa Respiratory Monitoring Devices Market Attractiveness Analysis
- 13.5.1. By Product
- 13.5.2. By End-user
- 13.5.3. By Country/Sub-region
14. Competition Landscape
- 14.1. Global Respiratory Monitoring Devices Market Share Analysis, by Company, 2021
- 14.2. Company Profiles
- 14.2.1. Medtronic
- 14.2.1.1. Company Description
- 14.2.1.2. Business Overview
- 14.2.1.3. Financial Overview
- 14.2.1.4. Strategic Overview
- 14.2.1.5. SWOT Analysis
- 14.2.2. Philips Healthcare (Koninklijke Philips N.V.)
- 14.2.2.1. Company Description
- 14.2.2.2. Business Overview
- 14.2.2.3. Financial Overview
- 14.2.2.4. Strategic Overview
- 14.2.2.5. SWOT Analysis
- 14.2.3. Smiths Medical (part of Smiths Group plc)
- 14.2.3.1. Company Description
- 14.2.3.2. Business Overview
- 14.2.3.3. Financial Overview
- 14.2.3.4. Strategic Overview
- 14.2.3.5. SWOT Analysis
- 14.2.4. Dragerwerk AG & Co. KGaA
- 14.2.4.1. Company Description
- 14.2.4.2. Business Overview
- 14.2.4.3. Financial Overview
- 14.2.4.4. Strategic Overview
- 14.2.4.5. SWOT Analysis
- 14.2.5. GE Healthcare (part of General Electric Company)
- 14.2.5.1. Company Description
- 14.2.5.2. Business Overview
- 14.2.5.3. Financial Overview
- 14.2.5.4. Strategic Overview
- 14.2.5.5. SWOT Analysis
- 14.2.6. Welch Allyn, Inc. (Hill-Rom Holdings, Inc.)
- 14.2.6.1. Company Description
- 14.2.6.2. Business Overview
- 14.2.6.3. Financial Overview
- 14.2.6.4. Strategic Overview
- 14.2.6.5. SWOT Analysis
- 14.2.7. Masimo
- 14.2.7.1. Company Description
- 14.2.7.2. Business Overview
- 14.2.7.3. Financial Overview
- 14.2.7.4. Strategic Overview
- 14.2.7.5. SWOT Analysis
- 14.2.8. MGC Diagnostics Corporation
- 14.2.8.1. Company Description
- 14.2.8.2. Business Overview
- 14.2.8.3. Financial Overview
- 14.2.8.4. Strategic Overview
- 14.2.8.5. SWOT Analysis
- 14.2.9. Vyaire Medical Inc. (Becton, Dickinson and Company and Apax Partners' Joint Venture)
- 14.2.9.1. Company Description
- 14.2.9.2. Business Overview
- 14.2.9.3. Financial Overview
- 14.2.9.4. Strategic Overview
- 14.2.9.5. SWOT Analysis
- 14.2.10. Nihon Kohden Corporation
- 14.2.10.1. Company Description
- 14.2.10.2. Business Overview
- 14.2.10.3. Financial Overview
- 14.2.10.4. Strategic Overview
- 14.2.10.5. SWOT Analysis
- 14.2.11. Novelda AS
- 14.2.11.1. Company Description
- 14.2.11.2. Business Overview
- 14.2.11.3. Financial Overview
- 14.2.11.4. Strategic Overview
- 14.2.11.5. SWOT Analysis